Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cal02 (1 trial)
Pneumococcal Infections (Phase 1)
Pneumonia (Phase 1)
Trials (1 total)
Trial APIs (1 total)